About 28 000 reports

The sepsis diagnostics market was valued at USD 550 million in 2020 and is expected to reach USD 975 million in 2026 by registering the CAGR of 9.8% during the forecast period. The coronavirus disease 2019 has proved to wreak havoc to health system leaders throughout the world. The healthcare systems across the world are witnessing...

  • Blood Disease
  • Diagnostics
  • World
  • Health Expenditure
  • Mortality Rate

The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious...

  • Molecular Diagnostics
  • World
  • North America
  • Health Expenditure
  • Cancer Incidence

China’s demand for Diagnostic Medical Equipment has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Medical Equipment
  • Diagnostics
  • China
  • Medical Devices Sales
  • Medical Technology Density

The global sepsis diagnostics market size is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9%. The demand is expected to grow due to the rising incidence of sepsis, a growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing availability of a wide variety...

  • Diagnostics
  • Blood Disease
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Surgical Procedures Performed
  • Mortality Rate

The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving the infectious disease diagnostics market growth. The market growth is attributed...

  • Infectious Disease
  • Diagnostics
  • World
  • APAC
  • Europe
  • Diagnostic Revenue
  • Health Expenditure

The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. Autoimmune diseases refer to a body’s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases prevailing...

  • Autoimmune Disease
  • Diagnostics
  • World
  • Health Expenditure
  • Auto-Immune Diseases Prevalence

The Liver cancer diagnostics market size is projected to reach US$ US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021; it is estimated to grow at a CAGR of 8.0% during 2021–2028. The report highlights the key factors driving the market and prominent players with their developments.The growth of the liver cancer diagnostics...

  • Liver Cancer
  • Diagnostics
  • World
  • APAC
  • Europe
  • Middle East
  • Health Expenditure
  • Mortality Rate

The women’s health diagnostics market is expected to register a CAGR of 7.5% over the forecast period. During the pandemic, limited transportation and travel restrictions created impediments for international trade and transportation, which disrupted the supply chains for the women’s health diagnostics market, temporarily leading to...

  • Diagnostics
  • Dietary Supplement
  • World
  • Health Expenditure
  • Cervical Cancer Screening Coverage

The Infectious Disease Diagnostics Market was estimated to be USD 38,480.89 million in 2021 and is poised to grow at a CAGR of 3.79% by 2027 to reach USD 50,345.74 million. The COVID-19 pandemic has significantly impacted the infectious disease diagnostics market. Increasing incidences of infection in COVID-19 patients is anticipated...

  • Infectious Disease
  • Diagnostics
  • World
  • Health Expenditure
  • HIV AIDS Prevalence

China’s demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • In Vitro Diagnostics
  • China
  • Industrial Production
  • Labour Force

The global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. "The...

  • Diagnostics
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Cancer Incidence
  • Health Expenditure

China’s demand for Patient Monitoring and Diagnostic Systems has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import...

  • Patient Monitoring
  • Diagnostics
  • China
  • Industrial Production
  • Labour Force

The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However,an unfavorable reimbursement scenario is expected...

  • Infectious Disease
  • Diagnostics
  • World
  • APAC
  • Health Expenditure
  • Disposable Income

China’s demand for Diagnostic Reagent has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Clinical Diagnostic
  • China
  • Industrial Production
  • Labour Force

The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing...

  • Molecular Diagnostics
  • World
  • Health Expenditure
  • Disposable Income

The global influenza diagnostics market is projected to reach USD 1.1 billion by 2026 from USD 0.8billion in 2021, at a CAGR of 7.7% during the forecast period. Market growth is driven by factors such as the growth in influenza research for diagnostic technologies,rising demand for rapid disease diagnosis and increasing prevalence of influenza....

  • Diagnostics
  • Influenza
  • World
  • United States
  • North America
  • APAC
  • Influenza Prevalence
  • Health Expenditure

The molecular diagnostics market is projected to grow from US$ 16,258.97 million in 2021 to US$ 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021–2028. The market growth is mainly attributed to an increase in demand for point-of-care devices, developments by market players, and a rise in the prevalence of associated...

  • Molecular Diagnostics
  • World
  • APAC
  • Europe
  • Middle East
  • Health Expenditure
  • Chronic Disease Prevalence

The automotive diagnostic scan tools market is estimated to be USD 33.1 billion in 2021 and is projected to grow at a CAGR of 4.5% during the forecast period, to reach a market size of USD 41.4 billion by 2026. An increase in the number of automotive workshops in organized as well as unorganized market has resulted in the increased demand...

  • Automotive
  • Diagnostics
  • World
  • APAC
  • Vehicle Production
  • Car Sales

The sleep apnea diagnostics market is projected to reach US$ 685.66 million by 2028 from US$ 473.95 million in 2021; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028. Factors such as increased sleep apnea prevalence, technological developments, and rising geriatric population are boosting the sleep apnea diagnostics market growth....

  • Diagnostics
  • World
  • APAC
  • Middle East
  • Diagnostic Revenue
  • Overweight Prevalence

The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028. The growth of the market is primarily attributed to the growing demand for specific viral detection methods that consume less time for timely infection...

  • Molecular Diagnostics
  • World
  • APAC
  • Cancer Incidence
  • Infectious Disease Incidence

The global circulating tumor cell (CTC) diagnostics market is projected to reach US$ 1,909.41 million by 2028 from US$ 3,656.38 million in 2021; it is expected to grow at a CAGR of 9.7% during 2021-2028. The market growth is mainly attributed to the increasing prevalence of cancer globally. A circulating tumor cell (CTC) is a cell...

  • Diagnostics
  • World
  • APAC
  • Europe
  • Diagnostic Revenue
  • Health Expenditure

The global allergy diagnostics market is projected to USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026. The growth of this market is driven owing to the high incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, increasing funds by organizations...

  • Allergy
  • Diagnostics
  • United States
  • World
  • North America
  • APAC
  • Allergy Prevalence
  • Asthma Prevalence

Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Product Landscape, 2021 Summary Medical Devices sector report, “Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Hepatitis Viruses Rapid Tests...

  • Hepatitis
  • Diagnostics
  • Clinical Trial
  • Hepatitis Testing
  • World
  • Interest Payments Paid By Central Government
  • Medical Devices Sales

The Chinese in-vitro diagnostics market is projected to register a CAGR of 6.6% during the forecast period. In-vitro diagnostics (IVDs) play an important role in the detection of infectious diseases. A large number of molecular assays and immunoassays are used for the detection of COVID-19. China represents one of the largest in-vitro...

  • In Vitro Diagnostics
  • China
  • Mortality Rate
  • Cervical Cancer Screening Coverage

China’s demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Cancer Diagnostics
  • China
  • Industrial Production
  • Labour Force

China In-Vitro Diagnostics (IVD) market is predicted to reach US$ 21 Billion by 2028. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. Historically, large multinational companies have dominated IVD market in China; today, domestic companies...

  • In Vitro Diagnostics
  • China
  • Health Expenditure
  • Diabetes Prevalence

The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028. The growth of the market is attributed to some of the key driving factors, such as increasing burden of chronic respiratory diseases...

  • Diagnostics
  • Respiratory Disease
  • Molecular Diagnostics
  • Europe
  • Diagnostic Revenue
  • Smoking Prevalence

The Asia Pacific PCR for respiratory infection diagnostics market is expected to reach US$ 1,515.94 million by 2028 from US$ 737.47 million in 2021; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028. The growth of the market is attributed to some of the key driving factors such as increasing developments in PCR technology...

  • Diagnostics
  • Respiratory Disease
  • Molecular Diagnostics
  • APAC
  • Diagnostic Revenue
  • Cervical Cancer Screening Coverage

The Middle East and Africa PCR for respiratory infection diagnostics market is expected to reach US$ 1,515.94 million by 2028 from US$ 737.47 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The growth of the market is attributed to some of the key driving factors, such as increasing burden of chronic respiratory...

  • Diagnostics
  • Respiratory Disease
  • Molecular Diagnostics
  • Middle East
  • Africa
  • Diagnostic Revenue
  • Health Expenditure

The South and Central America PCR for respiratory infection diagnostics market is expected to reach US$ 502.55 million by 2028 from US$ 262.55 million in 2021; it is estimated to grow at a CAGR of 9.7% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing burden of chronic...

  • Diagnostics
  • Respiratory Disease
  • Molecular Diagnostics
  • Central America
  • Diagnostic Revenue
  • Cervical Cancer Screening Coverage